MELD and PELD: Application of survival models to liver allocation
2001; Lippincott Williams & Wilkins; Volume: 7; Issue: 7 Linguagem: Inglês
10.1053/jlts.2001.25879
ISSN1527-6473
Autores Tópico(s)Liver Disease Diagnosis and Treatment
ResumoLiver TransplantationVolume 7, Issue 7 p. 567-580 Review ArticleFree Access MELD and PELD: Application of survival models to liver allocation Russell H. Wiesner, Corresponding Author Russell H. Wiesner MD [email protected] From the Liver Transplant Center, Mayo Clinic, Rochester, MNProfessor of Medicine, Liver Transplant Center, Mayo Clinic, 200 First St SW, Rochester, MN 55905. Telephone: 507-266-1586; FAX: 507-266-2810Search for more papers by this authorSue V. McDiarmid, Sue V. McDiarmid From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorPatrick S. Kamath, Patrick S. Kamath From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorEric B. Edwards, Eric B. Edwards From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorMichael Malinchoc, Michael Malinchoc From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorWalter K. Kremers, Walter K. Kremers From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorRuud A.F. Krom, Ruud A.F. Krom From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorW. Ray Kim, W. Ray Kim From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this author Russell H. Wiesner, Corresponding Author Russell H. Wiesner MD [email protected] From the Liver Transplant Center, Mayo Clinic, Rochester, MNProfessor of Medicine, Liver Transplant Center, Mayo Clinic, 200 First St SW, Rochester, MN 55905. Telephone: 507-266-1586; FAX: 507-266-2810Search for more papers by this authorSue V. McDiarmid, Sue V. McDiarmid From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorPatrick S. Kamath, Patrick S. Kamath From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorEric B. Edwards, Eric B. Edwards From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorMichael Malinchoc, Michael Malinchoc From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorWalter K. Kremers, Walter K. Kremers From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorRuud A.F. Krom, Ruud A.F. Krom From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this authorW. Ray Kim, W. Ray Kim From the Liver Transplant Center, Mayo Clinic, Rochester, MNSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jlts.2001.25879Citations: 679AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Anonymous. Organ procurement and transplantation network—HRSA. Final rule with comment period. Federal Register 1998; 63: 16296–16338. MEDLINE PubMedGoogle Scholar 2 Institute of Medicine. Analysis of waiting times. In: Committee on Organ Transplantation. Assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press, 1999: 57–78. Google Scholar 3 Freeman R, Edwards E. Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy. Liver Transpl 2000; 6: 543–552. MEDLINE 10.1053/jlts.2000.9744 PubMedWeb of Science®Google Scholar 4 Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3: 628–637. MEDLINE 10.1002/lt.500030613 CASPubMedGoogle Scholar 5 Child CG II, Turcotte JG. Surgery and portal hypertension. In: CG Child (ed) The liver and portal hypertension. Philadelphia: Saunders, 1964: 50–58. Google Scholar 6 Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1: 673–676. MEDLINE 10.1002/hep.1840010617 CASPubMedGoogle Scholar 7 Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–649. MEDLINE 10.1002/bjs.1800600817 CASPubMedWeb of Science®Google Scholar 8 Christensen E, Schlichting P, Fauerholdt L, Gluud C, Anderson PK, Juhl E, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1983; 3: 889–895. MEDLINE PubMedWeb of Science®Google Scholar 9 Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7: 660–664. MEDLINE 10.1002/hep.1840070408 CASPubMedWeb of Science®Google Scholar 10 Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25: 1049–1053. MEDLINE 10.1002/hep.510250501 CASPubMedWeb of Science®Google Scholar 11 Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999; 29: 1643–1648. MEDLINE 10.1002/hep.510290607 CASPubMedWeb of Science®Google Scholar 12 Abad-Lacruz A, Cabre E, Gonzalez-Huix F, Fernandez-Banares F, Esteve M, Planas R, et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of the Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol 1993; 88: 382–389. MEDLINE CASPubMedWeb of Science®Google Scholar 13 Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34: 46–52. MEDLINE 10.1016/S0168-8278(00)00011-8 CASPubMedWeb of Science®Google Scholar 14 Moroto A, Gines A, Salo J, Claria J, Gines P, Anibarro L, et al. Diagnosis of functional renal failure of cirrhosis by Doppler sonography. Prognostic value of resistive index. Hepatology 1994; 20: 839–844. MEDLINE 10.1002/hep.1840200411 PubMedWeb of Science®Google Scholar 15 Gines P, Fernandez Esparrach SG. Prognosis of cirrhosis with ascites. In: V Arroyo, P Gines, J Rodes, RW Schrier (eds). Ascites and renal dysfunction in liver disease. Oxford, UK: Blackwell Science, 1999: 431–441. Google Scholar 16 United Network for Organ Sharing. Policy 3.6. Allocation of livers. Available at: www.unos.org. Accessed: October 13, 2000. Google Scholar 17 Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network—Transplant Data 1990–1999. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 2000. Google Scholar 18 Robert A, Chazoulleres O. Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24: 1392–1394. MEDLINE 10.1002/hep.510240613 PubMedWeb of Science®Google Scholar 19 Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10: 1–7. MEDLINE 10.1002/hep.1840100102 CASPubMedWeb of Science®Google Scholar 20 Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710–1717. MEDLINE 10.1016/0016-5085(91)90673-9 CASPubMedWeb of Science®Google Scholar 21 Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: Natural history, prognostic factors, and survival analysis. Hepatology 1989; 10: 430–436. MEDLINE 10.1002/hep.1840100406 CASPubMedWeb of Science®Google Scholar 22 Orrego H, Israel Y, Blake JE, Medline A. Assessment of prognostic factors in alcoholic liver disease: Toward a global quantitative expression of severity. Hepatology 1983; 3: 896–905. MEDLINE 10.1002/hep.1840030602 PubMedWeb of Science®Google Scholar 23 Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Ranin L. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991; 86: 210–216. MEDLINE PubMedWeb of Science®Google Scholar 24 Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: Clinical presentation and use of prognostic index. Gut 1986; 27: 1377–1381. MEDLINE 10.1136/gut.27.11.1377 CASPubMedWeb of Science®Google Scholar 25 Schenker S. Alcoholic liver disease: Evaluation of natural history and prognostic factors. Hepatology 1984; 4: S36–S43. 10.1002/hep.1840040712 CASPubMedWeb of Science®Google Scholar 26 Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193–199. MEDLINE 10.1016/0016-5085(78)90401-8 CASPubMedWeb of Science®Google Scholar 27 Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21: 163–174. MEDLINE 10.3109/00365528609034642 PubMedWeb of Science®Google Scholar 28 D'Amico G, Marabito A, Pagliaro L, Marubini E, and the Liver Study Group. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468–475. MEDLINE 10.1007/BF01320309 PubMedWeb of Science®Google Scholar 29 Gines P, Quintero E, Arroyo V, Teres J, Burguera M, Rimola A, et al. Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7: 122–128. MEDLINE 10.1002/hep.1840070124 CASPubMedWeb of Science®Google Scholar 30 Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24: 269–276. MEDLINE 10.3109/00365528909093045 CASPubMedWeb of Science®Google Scholar 31 Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, et al. Aminopyrine breath test in prognostic evaluation of patients with cirrhosis. Gut 1992; 33: 836–842. MEDLINE 10.1136/gut.33.6.836 PubMedWeb of Science®Google Scholar 32 Beuers U, Jager F, Wahllander A, Ansari H, Kirsch CM. Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion 1991; 50: 212–218. MEDLINE 10.1159/000200763 PubMedWeb of Science®Google Scholar 33 Arrigoni A, Gindro T, Aimo G, Capello N, Meloni A, Benedetti P, et al. Monoethylglycinexylidide test: A prognostic indicator of survival in cirrhosis. Hepatology 1994; 20: 383–387. MEDLINE 10.1002/hep.1840200218 PubMedWeb of Science®Google Scholar 34 Oellerich M, Burdelski M, Lautz H-U, Binder L, Pichlmayr R. Predictors of one year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14: 1029–1034. MEDLINE 10.1002/hep.1840140614 PubMedGoogle Scholar 35 Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. J Hepatol 1996; 25: 474–480. MEDLINE 10.1016/S0168-8278(96)80206-6 PubMedWeb of Science®Google Scholar 36 Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 1988; 6: 350–358. MEDLINE 10.1016/S0168-8278(88)80053-9 CASPubMedWeb of Science®Google Scholar 37 Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981; 94: 198–201. MEDLINE 10.7326/0003-4819-94-2-198 PubMedWeb of Science®Google Scholar 38 Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ, Goldman L, et al. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997; 113: 1278–1288. MEDLINE 10.1053/gast.1997.v113.pm9322523 PubMedWeb of Science®Google Scholar 39 Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, terBorg PL. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864–871. MEDLINE 10.1053/he.2000.5852 CASPubMedWeb of Science®Google Scholar 40 Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464–470. MEDLINE 10.1053/jhep.2001.22172 CASPubMedWeb of Science®Google Scholar 41 Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29–36. MEDLINE 10.1148/radiology.143.1.7063747 CASPubMedWeb of Science®Google Scholar 42 Talwalkar JA, Seaberg E, Kim WR, Wiesner RH. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl 2000; 6: 753–758. MEDLINE 10.1053/jlts.2000.18485 CASPubMedWeb of Science®Google Scholar 43 Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal variceal detection? Hepatology 2001; 33: 333–338. MEDLINE 10.1053/jhep.2001.21410 CASPubMedWeb of Science®Google Scholar 44 Arroyo V, Gines P, Gerbes A, Dudley F, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164–176. MEDLINE 10.1002/hep.510230122 CASPubMedWeb of Science®Google Scholar 45 Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890–895. MEDLINE 10.1016/S0168-8278(99)80144-5 CASPubMedWeb of Science®Google Scholar 46 Graham D, Smith J. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–806. MEDLINE PubMedWeb of Science®Google Scholar 47 Altman C, Grange JD, Amiot X, Pelletier G, Lacaine F, Bodin F, et al. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation. J Gastroenterol Hepatol 1995; 10: 47–50. MEDLINE 10.1111/j.1440-1746.1995.tb01046.x PubMedWeb of Science®Google Scholar 48 Garrett KO, Reilly JJ, Schade RR, Van Thiel DW. Sclerotherapy of esophageal varices: Long-term results and determinants of survival. Surgery 1988; 104: 813–818. MEDLINE CASPubMedWeb of Science®Google Scholar 49 DiMagno EP, Zinsmeister AR, Larson DE, Viggiano TR, Clain JE, Laughlin BL, et al. Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: A retrospective analysis. Mayo Clin Proc 1985; 60: 149–157. MEDLINE 10.1016/S0025-6196(12)60211-0 CASPubMedWeb of Science®Google Scholar 50 Milliken WJ, Warren DW, Henderson JM, Smith RB, Salam AA, Galambos JT, et al. The Emory prospective randomized trial: Selective versus nonselective shunt to control variceal bleeding: Ten year follow-up. Ann Surg 1985; 201: 712–722. MEDLINE PubMedWeb of Science®Google Scholar 51 Everhart JE, Bereford TP. Liver transplantation for alcoholic liver disease: A survey of transplantation in the United States. Liver Transpl Surg 1997; 3: 220–226. MEDLINE 10.1002/lt.500030305 CASPubMedGoogle Scholar 52 Kim WR, Wiesner RH, Therneau T, Poterucha JJ, Porayko ME, Evans RW, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998; 28: 35–38. 10.1002/hep.510280106 Web of Science®Google Scholar 53 Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1121–1127. MEDLINE 10.1002/hep.510300501 CASPubMedWeb of Science®Google Scholar 54 Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 2000; 31: 7–11. MEDLINE 10.1002/hep.510310103 CASPubMedWeb of Science®Google Scholar 55 Mayo PSC Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336: 690–695. Google Scholar 56 Wiesner RH, Edwards EB, Kamath PS, Kim WR, Kremers WK, Freeman RB, et al. Mayo end-stage liver disease model (MELD) score predicts liver transplant waiting list mortality: Implications for liver allocation policy [abstract]. Transplantation 2001; 71(suppl 1): 461. Google Scholar 57 Freeman RB, Rohrer RS, Katz E, Lewis WD, Jenkin R, Cosimi AB, et al. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl 2001; 7: 173–178. MEDLINE 10.1053/jlts.2001.22180 CASPubMedWeb of Science®Google Scholar 58 McDiarmid S. 2000 Report of the Studies of Pediatric Liver Transplantation (SPLIT). Potomac, MD, EMMES Corp, 2000. Google Scholar 59 McDiarmid SV, Anand R, and SPLIT Research Group. Development of a pediatric end-stage liver disease score [abstract]. Transplantation 2001; 71(suppl 1): 461. Google Scholar 60 Swaminathan R, Major P, Snieder H, Spector T. Serum creatinine and fat-free mass (lean body mass). Clin Chem 2000; 46: 1695–1696. MEDLINE CASPubMedWeb of Science®Google Scholar 61 Cockroft RW, Gault MN. Prediction of creatinine clearance from creatinine. Nephron 1976; 16: 31–41. MEDLINE Google Scholar 62 Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999; 5: 192–199. MEDLINE 10.1002/lt.500050307 CASPubMedWeb of Science®Google Scholar 63 Mazzafero V, Regalia V, Doci E, Andreola S, Purvirent A. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693–699. MEDLINE 10.1056/NEJM199603143341104 PubMedWeb of Science®Google Scholar 64 Kim WR, Wiesner RH, Kamath PS, Malinchoc M, Kremers WK, Rosen CB, et al. Prediction of liver transplant outcome using the MELD scale [abstract]. Transplantation 2001; 71(suppl 1): 284. Google Scholar Citing Literature Volume7, Issue7July 2001Pages 567-580 ReferencesRelatedInformation
Referência(s)